封面
市场调查报告书
商品编码
1455767

全球食品补充品市场 - 2023-2030

Global Food Supplement Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 250 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年,全球食品补充剂市场规模达到1,728.9亿美元,预计2030年将达到3,451.3亿美元,2023-2030年预测期间CAGR为8.4%。

食品补充剂市场扩张的根本驱动力是人口老化是不可阻挡的全球趋势。随着年龄的增长,他们经常会遇到各种健康问题和疾病,包括免疫系统衰弱、关节问题和骨骼健康问题。老年人越来越被针对这些特定健康问题的食品补充剂所吸引。

新陈代谢的变化、食慾下降和难以维持健康饮食是老化的常见副作用。对于老年人来说,食品补充剂提供了一种实用的方法来满足他们的营养需求并保证他们获得重要的维生素、矿物质和其他营养素。老年人可能患有慢性健康问题,例如糖尿病、心血管问题或与年龄相关的黄斑部病变。

维生素成分细分市场占三分之一的市场份额,亚太地区在食品补充剂市场占据主导地位。由于意识、人口和可支配收入的增加,亚太地区膳食补充剂市场正在经历快速成长。由于人口老化等多种因素,印度、中国和日本等国家的需求也增加。

动力学

人口老化加剧

人口老化是不可逆转的全球趋势,也是市场发展的重要催化剂。随着年龄的增长,个人经常面临各种健康问题和状况,例如关节问题、骨骼健康问题、认知能力下降和免疫系统减弱。旨在解决这些特定健康问题的食品补充剂对老龄化人口更具吸引力。老化通常伴随着新陈代谢的变化、食慾下降以及维持均衡饮食的挑战。

认知能力下降是老年人普遍关心的问题。含有 omega-3 脂肪酸、抗氧化剂和其他被认为有助于大脑健康的营养素的补充剂通常面向老年人群,以促进认知功能和记忆力。因此,老龄化人口的增加有助于推动市场成长。例如,根据世界卫生组织2022年估计,60岁及以上人口比例将从2020年的10亿增加到14亿,到2050年,全球60岁及以上人口将翻倍(21亿) )。 2020 年至 2050 年间,80 岁及以上的人口数量预计将增加两倍,达到 4,260 亿。

增加营养的个性化

个人化营养可以更准确地识别个人营养缺乏或特定的健康目标。因此,食品补充剂製造商可以开发出满足这些特定需求的有针对性的产品,为消费者提供更量身定制和有效的解决方案。基因检测和个人化健康评估等技术进步使得客製化补充剂配方的创建成为可能。个人可以获得与其独特的基因组成、生活方式和健康状况相符的补充剂。这种程度的客製化增加了补充剂的感知价值,推动了消费者的兴趣和市场的成长。

个人化营养使消费者能够更好地控制自己的健康和福祉。随着人们越来越意识到自己的营养需求,他们可能会寻求满足其特定需求的个人化补充剂。这种对个人化解决方案的需求有助于食品补充剂市场的扩大。例如,国际食品资讯理事会2023年估计,北美消费者越来越被个人化营养产品所吸引。事实上,46% 的美国人希望获得更个人化的建议和解决方案来支持他们的健康。同样,55% 的加拿大成年人表示,他们会对基于 DNA 分析的营养计划感兴趣。目前,出现了两种主要的消费者群体,一种是有特定健康问题的老年人,另一种是数位化程度最高的一代(千禧世代和Z世代)。因此,上述因素有助于推动市场成长。

与食品补充剂相关的副作用

与食品补充剂相关的副作用会严重抑制市场的成长。消费者越来越担心他们所消费的产品的安全性和潜在的不利影响。副作用的存在可能导致消费者信心下降、监管审查和负面宣传。严重的副作用可能会导致产品召回,这不仅成本高昂,还会损害品牌声誉。由于与补充剂消费相关的健康问题而对製造商采取的法律行动也可能导致经济损失。例如,2023 年 10 月,Botanical-Be 回收了某些受双氯芬酸污染的膳食补充剂,根据 FDA 的说法,膳食补充剂中存在双氯芬酸等活性药物成分,导致这些产品未经批准。

服用过多的补充剂可能会导致患者增加人体内的毒性。服用过多的钙补充剂可能会导致结石或高钙血症。许多补充剂也会引起腹泻。有时,身体可能无法吸收这些补充剂,它们也可能会随着尿液被冲走。使用处方药的消费者可能会对与补充剂的潜在交互作用持谨慎态度。补充剂如何与现有药物相互作用的不确定性可能会阻碍一些人使用它们。因此,上述因素抑制了市场的成长。

目录

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按成分分类的片段
  • 按表格列出的片段
  • 按应用程式片段
  • 最终使用者的片段
  • 按配销通路分類的片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 人口老化加剧
      • 增加营养的个性化
    • 限制
      • 天然替代品与全食趋势
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章:按成分

  • 维生素
  • 植物药
  • 矿物质
  • 蛋白质和胺基酸
  • 欧米伽脂肪酸
  • 其他的

第 8 章:按形式

  • 药片
  • 胶囊
  • 软胶囊
  • 粉末
  • 软糖
  • 液体
  • 其他的

第 9 章:按应用

  • 能量和体重管理
  • 整体健康
  • 骨骼和关节健康
  • 肠胃健康
  • 免疫
  • 心臟健康
  • 糖尿病
  • 其他的

第 10 章:最终用户

  • 成年人
  • 老年科
  • 孕妇
  • 孩子们
  • 婴儿

第 11 章:按配销通路

  • 离线
  • 在线的

第 12 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第13章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 14 章:公司简介

  • Amway
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Abbott Laboratories
  • Bayer AG
  • Pfizer Inc
  • ADM
  • Carlyle Nutritionals LLC
  • Glanbia Plc
  • Haleon Plc
  • Otsuka Holdings Co Ltd
  • Herballife Ltd

第 15 章:附录

简介目录
Product Code: FB8228

Overview

Global Food Supplement Market reached US$ 172.89 billion in 2022 and is expected to reach US$ 345.13 billion by 2030, growing with a CAGR of 8.4% during the forecast period 2023-2030.

The essential driver of market expansion of food supplements is the aging population is an unstoppable global trend. As people get older, they frequently experience a variety of health difficulties and ailments, including immune system weakness, joint problems, and problems with bone health. The older population is increasingly drawn to food supplements made to target these particular health problems.

Changes in metabolism, decreased appetite, and difficulties keeping up a healthy diet are common side effects of aging. For older people, food supplements offer a practical means of fulfilling their nutritional needs and guaranteeing they get vital vitamins, minerals, and other nutrients. Older individuals may have chronic health conditions such as diabetes, cardiovascular issues, or age-related macular degeneration.

The vitamin ingredient segment accounts for one-third market share and Asia Pacific dominates the food supplement market. The Asia-Pacific dietary supplements market is experiencing rapid growth due to increasing awareness, population, and disposable incomes. Demand in countries like India, China, and Japan has also increased due to the aging population and other various factors.

Dynamics

Rise in the aging population

The aging population is an irreversible global trend that is a crucial catalyst for market development. With age, individuals often face various health concerns and conditions, such as joint issues, bone health problems, cognitive decline, and weakened immune systems. Food supplements designed to address these specific health issues become more appealing to the aging population. Aging is often accompanied by changes in metabolism, reduced appetite, and challenges in maintaining a balanced diet.

Cognitive decline is a common concern among the elderly. Supplements containing omega-3 fatty acids, antioxidants, and other nutrients believed to support brain health are often marketed to the aging population to promote cognitive function and memory. Thus, the rise of the aging population helps to boost the market growth. For instance, according to WHO 2022, estimated that the share of the population aged 60 years and over, will increase from 1 billion in 2020 to 1.4 billion, by 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 billion.

Increasing the personalization of nutrition

Personalized nutrition allows for more precise identification of individual nutrient deficiencies or specific health goals. As a result, food supplement manufacturers can create targeted products that address these specific needs, offering consumers a more tailored and effective solution. Advances in technology, such as genetic testing and personalized health assessments, enable the creation of customized supplement formulations. Individuals can receive supplements that align with their unique genetic makeup, lifestyle, and health conditions. This level of customization increases the perceived value of supplements, driving consumer interest and market growth.

Personalized nutrition empowers consumers by giving them greater control over their health and well-being. As people become more conscious of their nutritional requirements, they are likely to seek out personalized supplements that cater to their specific needs. This demand for personalized solutions contributes to the expansion of the food supplements market. For instance, to International Food Information Council, 2023, estimated that North American consumers are increasingly attracted to personalized nutrition products. Indeed, 46% of Americans would like more personalized advice and solutions to support their health. Similarly, 55% of Canadian adults say they would be interested in a nutritional plan based on DNA analysis. Currently, two main consumer profiles are emerging, one is senior citizens with specific health problems, and the other is the most digital generation (Millennials and Generation Z). Thus, the above factors help to boost the market growth.

Side effects associated with food supplements

Side effects associated with food supplements can significantly restrain the growth of the market. Consumers are increasingly concerned about the safety and potential adverse effects of the products they consume. The presence of side effects can lead to a decline in consumer confidence, regulatory scrutiny, and negative publicity. Serious side effects may lead to product recalls, which can be costly and damaging to a brand's reputation. Legal action against manufacturers due to health issues linked to supplement consumption can also result in financial losses. For instance, in October 2023, Botanical-Be recalls certain dietary supplements tainted with diclofenac, according to the FDA, the presence of an active pharmaceutical ingredient such as diclofenac in a dietary supplement renders these products unapproved drugs.

Taking too many supplements may cause patients to increase the toxicity in the human body. Taking too many calcium supplements may lead to stones or hypercalcemia. Many supplements also cause diarrhea. Sometimes the body might not absorb these supplements and they could be washed away in the urine as well. Consumers, using prescription medications may be cautious about potential interactions with supplements. The uncertainty about how supplements may interact with existing medications can discourage some individuals from using them. Thus, above factors restrain market growth.

Segment Analysis

The global food supplement market is segmented based on ingredient, form, application, end-user distribution channel and region.

Rise in Vitamin Deficiency

Certain vitamins, such as vitamin C and vitamin D, play a crucial role in supporting the immune system. During times of increased susceptibility to illness or when the body is under stress, vitamin supplements can provide an extra layer of immune support. Vitamins like D and K are essential for bone health and calcium absorption. In cases where dietary sources are insufficient, supplements can help maintain strong and healthy bones, reducing the risk of conditions like osteoporosis. B-complex vitamins, including B1, B2, B3, B6, and B12, are integral for energy metabolism. Supplements can contribute to sustained energy levels, making them particularly relevant for individuals with increased energy demands or those experiencing fatigue.

Insufficient intake of vitamin A can affect vision and immune function, while a lack of vitamin K may impair blood clotting. It is essential to maintain a well-balanced diet to prevent such deficiencies, but in some cases, supplementation may be necessary, especially for individuals with specific dietary restrictions or medical conditions affecting nutrient absorption. Regular health check-ups and consultations with healthcare professionals can help identify and address potential vitamin deficiencies. Thus, the rise of vitamin deficiency helps to boost the segment growth. For instance, according to World in Data 2021. Globally, it's estimated that over half of children under five years old are micronutrient deficient (in at least one of iron, zinc, and vitamin A). In addition, over two-thirds of non-pregnant women of reproductive age are micronutrient deficient (in at least one of iron, zinc, and folate also known as vitamin B9)

Geographical Penetration

Growing Awareness about Food Supplements in Asia-Pacific

The Asia-Pacific dietary supplements market is experiencing rapid growth due to increasing awareness, population, and disposable incomes. Demand in countries like India, China, and Japan has also increased due to the ageing population and other various factors. In China, the food supplements terminology is mentioned as Health Food which refers to foods that claim to have specific health functions or provide vitamins and minerals. It is specific to certain groups and modifies organic functions in humans, but is not intended to treat disease and does not cause acute, sub-acute, or chronic harm to the human body.

In 2021, the scope of health food filing was expanded. In addition, according to the drafts issued by SAMR on 20 December 2021, 6 ingredients including DHA, soybean protein isolate, whey protein, etc., will be added to the health food raw material directory, which means, more ingredients will be available for health food filing in the future. On the other hand, after the abolishment of Technical Standards for Testing & Assessment of healthy food, the registration tests of new products in China have been suspended. At present, most test methods have been officially issued, and it can be expected the functional assessment methods will be released in 2022. Meanwhile, China authorities paid great attention to the R&D materials during the technical review of product registration dossiers, and sufficient scientific literature support is a focus of the review. Therefore, when preparing the registration dossier, enterprises shall attach importance to the collection of them.

COVID-19 Impact Analysis

The COVID-19 pandemic led to widespread disruptions in global supply chains, affecting the production and distribution of various goods, including dietary supplements. Restrictions on movement, lockdown measures, and workforce shortages disrupted the supply of raw materials and manufacturing processes for Food Supplement. This resulted in delays in production, shortages in supply, and increased costs for manufacturers, impacting the availability of Food Supplement in the market.

However, the pandemic prompted a shift in consumer priorities towards health and wellness. With heightened awareness of immune health and overall well-being, there was increased interest in dietary supplements, including those containing isoflavones. Consumers sought products that could potentially support their immune systems and help manage stress and anxiety during uncertain times. This shift in consumer behavior led to a surge in demand for Food supplements, particularly those marketed for their potential health benefits.

By Ingredient

  • Vitamins
  • Vitamins
  • Botanicals
  • Minerals
  • Proteins and Amino Acids
  • Omega Fatty Acids
  • Others

By Form

  • Tablet
  • Capsules
  • Soft Gels
  • Powders
  • Gummies
  • Liquids
  • Others

By Application

  • Energy and Weight Management
  • General Health
  • Bone and Joint Health
  • Gastrointestinal Health
  • Immunity
  • Cardiac Health
  • Diabetes
  • Others

By End-User

  • Adults
  • Geriatric
  • Pregnant Women
  • Children
  • Infants

By Distribution Channel

  • Offline
  • Online

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, a new brand from Abbott Laboratories (PROTALITY) was launched into the market in 2024 to improve the product portfolio of Abbott nutrition, a part of Abbott Laboratories. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining muscle mass and good nutrition.
  • In February 2024, Performance Lab launched nine new single-supplement nutrients. The nine supplements include Vitamin B-Complex, Calcium, Iron Complex, Magnesium, Potassium and Vitamin C, as well as the lesser known, but most important, Iodine, Selenium and Zinc.
  • In September 2023, Probiotix Health Plc launched a new formulation designed for high end heart health supplements and online brands in the nutraceuticals market looking to expand cardiovascular health offerings.

Competitive Landscape

The major global players in the market include Amway, Abbott Laboratories, Bayer AG, Pfizer Inc, ADM, Carlyle Nutritionals LLC, Haleon Plc, Glanbia Plc, Otsuka Holdings Co Ltd, Herbalife Ltd are strategically partnering with healthcare professionals, nutritionists, and dietitians

Why Purchase the Report?

  • To visualize the global Food Supplement market segmentation based on Ingredient, form, application, end user, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of food supplements at the market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global Food Supplement market report would provide approximately 78 tables, 85 figures, and 250 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Ingredient
  • 3.2.Snippet by Form
  • 3.3.Snippet by Application
  • 3.4.Snippet by End User
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rise in aging population
      • 4.1.1.2.Increasing the personalization of nutrition
    • 4.1.2.Restraints
      • 4.1.2.1.The natural Alternatives and Whole foods trend
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Ingredient

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredients
    • 7.1.2.Market Attractiveness Index, By Ingredients
  • 7.2.Vitamins*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Botanicals
  • 7.4.Minerals
  • 7.5.Proteins and Amino Acids
  • 7.6.Omega Fatty Acids
  • 7.7.Others

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Tablet*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Capsules
  • 8.4.Soft Gels
  • 8.5.Powders
  • 8.6.Gummies
  • 8.7.Liquids
  • 8.8.Others

9.By Application

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2.Market Attractiveness Index, By Application
  • 9.2.Energy and Weight Management*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.General Health
  • 9.4.Bone and Joint Health
  • 9.5.Gastrointestinal Health
  • 9.6.Immunity
  • 9.7.Cardiac Health
  • 9.8.Diabetes
  • 9.9.Others

10.By End User

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2.Market Attractiveness Index, By End User
  • 10.2.Adults*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Geriatric
  • 10.4.Pregnant Women
  • 10.5.Children
  • 10.6.Infants

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Offline*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Online

12.By Region

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2.Market Attractiveness Index, By Region
  • 12.2.North America
    • 12.2.1.Introduction
    • 12.2.2.Key Region-Specific Dynamics
    • 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1.U.S.
      • 12.2.8.2.Canada
      • 12.2.8.3.Mexico
  • 12.3.Europe
    • 12.3.1.Introduction
    • 12.3.2.Key Region-Specific Dynamics
    • 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1.Germany
      • 12.3.8.2.UK
      • 12.3.8.3.France
      • 12.3.8.4.Italy
      • 12.3.8.5.Russia
      • 12.3.8.6.Rest of Europe
  • 12.4.South America
    • 12.4.1.Introduction
    • 12.4.2.Key Region-Specific Dynamics
    • 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1.Brazil
      • 12.4.8.2.Argentina
      • 12.4.8.3.Rest of South America
  • 12.5.Asia-Pacific
    • 12.5.1.Introduction
    • 12.5.2.Key Region-Specific Dynamics
    • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1.China
      • 12.5.8.2.India
      • 12.5.8.3.Japan
      • 12.5.8.4.Australia
      • 12.5.8.5.Rest of Asia-Pacific
  • 12.6.Middle East and Africa
    • 12.6.1.Introduction
    • 12.6.2.Key Region-Specific Dynamics
    • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13.Competitive Landscape

  • 13.1.Competitive Scenario
  • 13.2.Market Positioning/Share Analysis
  • 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

  • 14.1. Amway*
    • 14.1.1.Company Overview
    • 14.1.2.Product Portfolio and Description
    • 14.1.3.Financial Overview
    • 14.1.4.Key Developments
  • 14.2.Abbott Laboratories
  • 14.3.Bayer AG
  • 14.4.Pfizer Inc
  • 14.5.ADM
  • 14.6.Carlyle Nutritionals LLC
  • 14.7.Glanbia Plc
  • 14.8.Haleon Plc
  • 14.9.Otsuka Holdings Co Ltd
  • 14.10.Herballife Ltd

LIST NOT EXHAUSTIVE

15.Appendix

  • 15.1.About Us and Services
  • 15.2.Contact Us